Italia markets closed

SWTX Jul 2024 45.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
3,27000,0000 (0,00%)
Alla chiusura: 09:52AM EDT
Schermo intero
Chiusura precedente3,2700
Aperto3,2700
Denaro0,0000
Domanda2,7500
Prezzo d'esercizio45,00
Scadenza2024-07-19
Min-Max giorno3,2700 - 3,2700
Contratto - Min-MaxN/D
Volume5
Open Interest7
  • GlobeNewswire

    SpringWorks Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

    – Presented additional Phase 3 DeFi data at ASCO demonstrating clinically significant reductions in pain and substantial reductions in tumor volume and T2 hyperintensity with nirogacestat treatment – – Completed enrollment of Phase 2 trial evaluating nirogacestat in patients with ovarian granulosa cell tumors – – Highlighted encouraging Phase 1 and 2 clinical data from emerging pipeline programs at AACR and EHA – STAMFORD, Conn., Aug. 02, 2023 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (